Lytix Biopharma AS (OSL:LYTIX)
Norway
· Delayed Price · Currency is NOK 6.00
+0.40 (7.14%)
May 13, 2025, 1:27 PM CET
Lytix Biopharma AS Market Cap
Lytix Biopharma AS has a market cap or net worth of 382.27 million as of May 13, 2025. Its market cap has increased by 77.99% in one year.
Market Cap
382.27M
Enterprise Value
254.12M
Revenue
11.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.00
Market Cap Chart
Since June 14, 2021, Lytix Biopharma AS's market cap has decreased from 720.55M to 382.27M, a decrease of -46.95%. That is a compound annual growth rate of -14.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 382.27M | -4.76% |
| Dec 30, 2024 | 401.38M | 106.12% |
| Dec 29, 2023 | 194.73M | -37.37% |
| Dec 30, 2022 | 310.93M | -41.63% |
| Dec 30, 2021 | 532.66M | -26.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 3.57B |
| Nordhealth AS | 2.77B |
| Photocure ASA | 1.33B |
| Vistin Pharma ASA | 1.10B |
| Nykode Therapeutics AS | 914.33M |
| ArcticZymes Technologies ASA | 880.98M |
| Hofseth BioCare ASA | 871.49M |
| Gentian Diagnostics ASA | 869.82M |